Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 18 Prostatic Neoplasms 8 Osteoporosis 8 Vitamin D Deficiency 4 Polycystic Ovary Syndrome 4 Colonic Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms 3 Colorectal Neoplasms 3 Bone Diseases, Metabolic 3 Obesity 2 Neoplasm Metastasis 2 Multiple Endocrine Neoplasia Type 1 2 Lymphoma 2 Lung Neoplasms 2 Leukemia 2 Inflammation 2 Cardiovascular Diseases 2 Carcinoma, Transitional Cell 2 Brain Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Thyroid Neoplasms 1 Solid Cancers 1 Sexual Dysfunction, Physiological 1 Rectal Neoplasms 1 Psoriasis 1 Pancreatic Neoplasms 1

Interventions

nintedanib 1 Vitamin D 1 Surveys and Questionnaires 1 Paclitaxel 1 Cholecalciferol 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Melanoma, Cutaneous Malignant × Vitamin D × Clear all

NCT01748448 2025-02-17

ViDMe

Universitaire Ziekenhuizen KU Leuven

Phase 3 Completed

436 enrolled 16 charts

Melanoma, Cutaneous Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡